Jemperli 500 mg/10 ml

Jemperli 500 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 68023. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 February 2022 and the authorisation is limited until 21 December 2028. ATC code L01FF07 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68023
  • ATC L01FF07
  • Biotechnological medicines
Authorisation data
Authorisation number68023
NameJemperli 500 mg/10 ml
Full nameJemperli 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderGlaxoSmithKline AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FF07
First authorisation17 February 2022
Authorisation validity21 December 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Jemperli 500 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungA17 February 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FF0707.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Jemperli 500 mg/10 ml authorised in Switzerland?

Yes. Jemperli 500 mg/10 ml is authorised by Swissmedic under authorisation number 68023, data as of 01 September 2026. The authorisation is limited until 21 December 2028.

Which dispensing category does Jemperli 500 mg/10 ml have?

Jemperli 500 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Jemperli 500 mg/10 ml?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com